1. Homepagina
  2. Aandelen
  3. Denemarken
  4. Nasdaq Copenhagen
  5. Zealand Pharma A/S
  6. Nieuws
  7. Persberichten
    ZEAL   DK0060257814

ZEALAND PHARMA A/S

(ZEAL)
  Rapport
Vertraagde tijd Nasdaq Copenhagen  -  16:59 12-08-2022
118.00 DKK   -10.74%
12/08Europese ADR's bewegen iets lager in de vrijdaghandel
MT
11/08Europese ADR's bewegen lager in de donderdaghandel
MT
11/08Zealand Pharma Verliest in H1 Nettobedrijfsverlies door lagere inkomsten; is van plan ADS's van notering op Nasdaq te halen
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť ZEALAND PHARMA A/S
11/08Zealand Pharma Announces Financial Results for the First Half of 2022
GL
11/08Zealand Pharma Announces Financial Results for the First Half of 2022
AQ
08/08Updated notice to holders of ADSs regarding termination of Deposit Agreement
GL
08/08Updated notice to holders of ADSs regarding termination of Deposit Agreement
AQ
08/08Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S..
GL
08/08Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S..
AQ
04/08Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Seco..
GL
04/08Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Seco..
AQ
15/06Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
GL
15/06Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
AQ
10/06ZEALAND PHARMA MAJOR SHAREHOLDER ANN : Credit Suisse Group AG, 2022
GL
10/06ZEALAND PHARMA MAJOR SHAREHOLDER ANN : Credit Suisse Group AG, 2022
AQ
07/06Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual Ameri..
GL
07/06Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual Ameri..
AQ
03/06Zealand Pharma completes registration of capital increase
GL
03/06Zealand Pharma completes registration of capital increase
GL
03/06Zealand Pharma to†Participate in†Upcoming Investor Conferences
GL
03/06Zealand Pharma to†Participate in†Upcoming Investor Conferences
AQ
02/06ZEALAND PHARMA A/S : launches long-term incentive program for Zealand's Corporate Manageme..
PU
02/06Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Office..
GL
02/06Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Office..
AQ
01/06Zealand Pharma announces directed issue and private placement corresponding to approx. ..
GL
01/06Zealand Pharma announces directed issue and private placement corresponding to approx. ..
GL
31/05Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
GL
31/05Zealand Pharma Announces Multiple Presentations at the 82nd Annual American Diabetes As..
GL
31/05Zealand Pharma Announces Multiple Presentations at the 82nd Annual American Diabetes As..
GL
25/05Zealand Pharma launches long-term incentive program for Zealand's Corporate Management ..
GL
25/05Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
GL
25/05Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
GL
25/05Biotech Recovery Accelerates These Companies Benefit (IPA, SIGA, MNKD, INO, CTIC)
AQ
24/05ZEALAND PHARMA A/S : Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pedi..
PU
20/05ZEALAND PHARMA A/S : Announces Asset Purchase Agreement with MannKind Corporation for V-Go..
PU
19/05Zealand Pharma Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pediatr..
GL
19/05Zealand Pharma Announces Positive Results from Phase 3 Trial of Dasiglucagon in Pediatr..
AQ
17/05Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Goģ I..
GL
17/05Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Goģ I..
AQ
12/05Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
GL
12/05Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
GL
12/05Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
GL
12/05Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
AQ
12/05Zealand Pharma Provides Update on Refocused Strategy Prioritizing Research and Developm..
GL
12/05Zealand Pharma Provides Update on Refocused Strategy Prioritizing Research and Developm..
GL
10/05ZEALAND PHARMA MAJOR SHAREHOLDER ANN : Credit Suisse Group AG, 2022
GL
10/05ZEALAND PHARMA MAJOR SHAREHOLDER ANN : Credit Suisse Group AG, 2022
AQ
10/05Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company's Re..
GL
05/05Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Q..
GL
05/05Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Q..
AQ
22/04ZEALAND PHARMA A/S : launches long-term incentive program for Zealand's Board of Directors..
PU
22/04Transactions in Zealand Pharma A/S securities by persons discharging managerial respons..
AQ
20/04Zealand Pharma launches long-term incentive program for Zealand's Board of Directors fo..
AQ
11/04ZEALAND PHARMA A/S : AGM Minutes
PU
08/04ZEALAND PHARMA A/S : Presentation from the Annual General Meeting
PU
07/04CORRECTION : Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 202..
GL
07/04CORRECTION : Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 202..
GL
07/04ZEALAND PHARMA MAJOR SHAREHOLDER ANN : The Capital Group Companies, April 7 2022
AQ
06/04Zealand Pharma's Annual General Meeting 2022
GL
06/04ZEALAND PHARMA A/S : Voting Results
PU
05/04ZEALAND PHARMA A/S : Amendment to Annual Report by Foreign Issuer (Form 20-F/A)
PU
04/04Zealand Pharma to†Participate in†21st Annual Needham Virtual Healthcare Conference
AQ
30/03ZEALAND PHARMA A/S : Appoints New Chief Executive Officer, Refocuses Strategy to Prioritiz..
PU
30/03Zealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize R..
AQ
15/03ZEALAND PHARMA : Significant Advancement of Clinical Pipeline and Building Commercial Mome..
PU
14/03ZEALAND PHARMA A/S : Notice to convene the Annual General Meeting of Zealand Pharma A/S (C..
PU
11/03CORRECTION : Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Com..
GL
11/03CORRECTION : Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Com..
GL
11/03Zealand Pharma - Significant Advancement of Clinical Pipeline and Building Commercial M..
AQ
10/03Zealand Pharma convenes its Annual General Meeting 2022
GL
10/03ZEALAND PHARMA : Significant Advancement of Clinical Pipeline and Building Commercial Mome..
AQ
03/03Zealand Pharma Hosts Conference Call on March 10 at 4 pm CET (10am ET) to Present Full ..
AQ
25/02ZEALAND PHARMA MAJOR SHAREHOLDER ANN : The Capital Group Companies, 2022
AQ
15/02Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with C..
AQ
20/01Zealand Pharma Completes Enrollment in EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide ..
AQ
19/01ZEALAND PHARMA MAJOR SHAREHOLDER ANN : The Capital Group Companies, January 2022
AQ
12/01Scandion Oncology enhances its external communication
AQ
03/01Zealand Pharma to†Participate in†H.C. Wainwright BIOCONNECT 2022 Conference
AQ
1  2  3  4  5  6Volgende
Volgende evenement op ZEALAND PHARMA A/S